The aim of this Cochrane review was to find out whether cognitive‐behavioural treatment (CBT) is effective to treat people with amphetamine‐type stimulants (ATS)‐use disorders. Researchers in the Drugs and Alcohol Group of Cochrane collected and analysed all relevant studies to answer this question and found two studies. The review authors found two eligible studies. Both studies were conducted in Australia. One study compared a single session of brief CBT to a waiting‐list control where participants received no treatment during the study period. One study compared web‐based CBT to a waiting‐list control. Both studies were funded by the Australian Government of Health and Ageing. The review showed that when participants received CBT, co...
Objective: To systematically review the literature on published randomized controlled trials (RCTs) ...
AIMS Stimulant use disorder contributes to a substantial worldwide burden of disease, although evid...
AIMS:Stimulant use disorder contributes to a substantial worldwide burden of disease, although evide...
Background Amphetamine‐type stimulants (ATS) refer to a group of synthetic stimulants including amph...
Aims: The present study sought to replicate and extend a small pilot study conducted by Baker, Boggs...
Aims: The present study sought to replicate and extend a small pilot study conducted by Baker, Boggs...
Aims: To identify whether brief cognitive-behavioural interventions are feasible among regular users...
Introduction: Amphetamine-type stimulants (ATS) use is a global concern due to increased usage and t...
This trial of cognitive-behavioural therapy (CBT) based amphetamine abstinence program (n = 507) foc...
A brief intervention using motivational and cognitive behavioural approaches to help change drug use...
An estimated 14.352.5 million people worldwide use meth/amphetamine (used here to refer to amphetami...
Background: The prevalence of amphetamine-type stimulant use is greater than that of opioids and coc...
Background: The use of amphetamine-type stimulants (ATS) places a large burden on health services. O...
Background: Among illicit drugs, the prevalence of amphetamine-type stimulant (ATS) use is second on...
Abstract Background Previous studies of psychological treatment in adults with ADHD have not control...
Objective: To systematically review the literature on published randomized controlled trials (RCTs) ...
AIMS Stimulant use disorder contributes to a substantial worldwide burden of disease, although evid...
AIMS:Stimulant use disorder contributes to a substantial worldwide burden of disease, although evide...
Background Amphetamine‐type stimulants (ATS) refer to a group of synthetic stimulants including amph...
Aims: The present study sought to replicate and extend a small pilot study conducted by Baker, Boggs...
Aims: The present study sought to replicate and extend a small pilot study conducted by Baker, Boggs...
Aims: To identify whether brief cognitive-behavioural interventions are feasible among regular users...
Introduction: Amphetamine-type stimulants (ATS) use is a global concern due to increased usage and t...
This trial of cognitive-behavioural therapy (CBT) based amphetamine abstinence program (n = 507) foc...
A brief intervention using motivational and cognitive behavioural approaches to help change drug use...
An estimated 14.352.5 million people worldwide use meth/amphetamine (used here to refer to amphetami...
Background: The prevalence of amphetamine-type stimulant use is greater than that of opioids and coc...
Background: The use of amphetamine-type stimulants (ATS) places a large burden on health services. O...
Background: Among illicit drugs, the prevalence of amphetamine-type stimulant (ATS) use is second on...
Abstract Background Previous studies of psychological treatment in adults with ADHD have not control...
Objective: To systematically review the literature on published randomized controlled trials (RCTs) ...
AIMS Stimulant use disorder contributes to a substantial worldwide burden of disease, although evid...
AIMS:Stimulant use disorder contributes to a substantial worldwide burden of disease, although evide...